{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:49:21Z","timestamp":1792043361743,"version":"4.4.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It is well recognized that Attention-deficit\/hyperactivity disorder (ADHD) is associated with heightened risk for common psychiatric disorders; early identification and treatment of ADHD may help reduce some of this risk. However, the substantially increased risk of bipolar disorder, psychosis, and schizophrenia (hereafter psychotic disorders) is often overlooked (odds ratios 4.7\u20138.9). Given how common ADHD is, there is growing pressure for greater involvement of primary care services, especially for less complex forms of ADHD. However, those at highest risk for transition to a psychotic disorder need to be prioritised for secondary care follow up. Currently it is unknown how to stratify ADHD according to risk or indeed why only some develop a psychotic disorder. This perspective examines key hypotheses that may explain why transition occurs only in a subset of individuals. One hypothesis is that features suggestive of ADHD may represent early manifestations of psychotic disorders, although direct support for this is limited. The potential role of ADHD treatment is also considered; current data indicate that therapeutic use of methylphenidate is not associated with increased risk of psychotic disorders, while uncertainty remains for amphetamines. The possible mediating roles of ADHD-evoked environmental exposures are discussed, but evidence for mediation is lacking. We also consider the evidence that ADHD and psychotic disorders result from shared underlying neurodevelopmental processes. We highlight key clinical implications for screening and monitoring individuals with ADHD for psychotic disorders and consider what factors may help in weighting risk. Finally, we identify important evidence gaps for future research.<\/jats:p>","DOI":"10.1038\/s41380-026-03926-4","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:05:14Z","timestamp":1792001114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attention deficit hyperactivity disorder: transition to psychotic disorders"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3689-737X","authenticated-orcid":false,"given":"Anita","family":"Thapar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7493-2041","authenticated-orcid":false,"given":"Charlotte A.","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6940-0940","authenticated-orcid":false,"given":"Ali","family":"Kande\u011fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4798-0862","authenticated-orcid":false,"given":"Michael J.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"3926_CR1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jad.2023.07.071","volume":"339","author":"G Ayano","year":"2023","unstructured":"Ayano G, Demelash S, Gizachew Y, Tsegay L, Alati R. The global prevalence of attention deficit hyperactivity disorder in children and adolescents: an umbrella review of meta-analyses. J Affect Disord. 2023;339:860\u20136.","journal-title":"J Affect Disord"},{"key":"3926_CR2","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115449","volume":"328","author":"G Ayano","year":"2023","unstructured":"Ayano G, Tsegay L, Gizachew Y, Necho M, Yohannes K, Abraha M, et al. Prevalence of attention deficit hyperactivity disorder in adults: umbrella review of evidence generated across the globe. Psychiatry Res. 2023;328:115449.","journal-title":"Psychiatry Res"},{"key":"3926_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41380-025-03178-8","volume":"31","author":"S Johnson","year":"2026","unstructured":"Johnson S, Lim E, Jacoby P, Faraone SV, Su BM, Solmi M, et al. Prevalence of attention deficit hyperactivity disorder\/hyperkinetic disorder of pediatric and adult populations in clinical settings: a systematic review, meta-analysis and meta-regression. Mol Psychiatry. 2026;31:576\u201386.","journal-title":"Mol Psychiatry"},{"key":"3926_CR4","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1343314","volume":"15","author":"B French","year":"2024","unstructured":"French B, Nalbant G, Wright H, Sayal K, Daley D, Groom MJ, et al. The impacts associated with having ADHD: an umbrella review. Front Psychiatry. 2024;15:1343314.","journal-title":"Front Psychiatry"},{"key":"3926_CR5","doi-asserted-by":"crossref","first-page":"e0277175","DOI":"10.1371\/journal.pone.0277175","volume":"17","author":"W-S Choi","year":"2022","unstructured":"Choi W-S, Woo YS, Wang S-M, Lim HK, Bahk W-M. The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: a systematic literature review. PLOS ONE. 2022;17:e0277175.","journal-title":"PLOS ONE"},{"key":"3926_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jad.2022.10.016","volume":"321","author":"FM Villa","year":"2023","unstructured":"Villa FM, Crippa A, Rosi E, Nobile M, Brambilla P, Delvecchio G. ADHD and eating disorders in childhood and adolescence: an updated minireview. J Affect Disord. 2023;321:265\u201371.","journal-title":"J Affect Disord"},{"key":"3926_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-025-02774-7","volume":"14","author":"HM Magdi","year":"2025","unstructured":"Magdi HM, Abousoliman AD, lbrahim AM, Elsehrawy MG, EL-Gazar HE, Zoromba MA. Attention-deficit\/hyperactivity disorder and post-traumatic stress disorder adult comorbidity: a systematic review. Syst Rev. 2025;14:41.","journal-title":"Syst Rev"},{"key":"3926_CR8","volume":"99","author":"J Kang","year":"2024","unstructured":"Kang J, Lee H, Kim S, Kim HJ, Lee H, Kwon R, et al. Comorbid health conditions in people with attention-deficit\/hyperactivity disorders: an umbrella review of systematic reviews and meta-analyses. Asian J Psychiatry. 2024;99:104135.","journal-title":"Asian J Psychiatry"},{"key":"3926_CR9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1177\/1087054719886372","volume":"25","author":"M-R Mohammadi","year":"2021","unstructured":"Mohammadi M-R, Zarafshan H, Khaleghi A, Ahmadi N, Hooshyari Z, Mostafavi S-A, et al. Prevalence of ADHD and its comorbidities in a population-based sample. J Atten Disord. 2021;25:1058\u201367.","journal-title":"J Atten Disord"},{"key":"3926_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105625","volume":"160","author":"R Uher","year":"2024","unstructured":"Uher R, Pavlova B, Najafi S, Adepalli N, Ross B, Howes Vallis E, et al. Antecedents of major depressive, bipolar, and psychotic disorders: a systematic review and meta-analysis of prospective studies. Neurosci Biobehav Rev. 2024;160:105625.","journal-title":"Neurosci Biobehav Rev"},{"key":"3926_CR11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jad.2021.06.033","volume":"293","author":"GE Brancati","year":"2021","unstructured":"Brancati GE, Perugi G, Milone A, Masi G, Sesso G. Development of bipolar disorder in patients with attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis of prospective studies. J Affect Disord. 2021;293:186\u201396.","journal-title":"J Affect Disord"},{"key":"3926_CR12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jamapsychiatry.2020.4799","volume":"78","author":"M Nourredine","year":"2021","unstructured":"Nourredine M, Gering A, Fourneret P, Rolland B, Falissard B, Cucherat M, et al. Association of attention-deficit\/hyperactivity disorder in childhood and adolescence with the risk of subsequent psychotic disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78:519\u201329.","journal-title":"JAMA Psychiatry"},{"key":"3926_CR13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/acps.13283","volume":"143","author":"A Sandstrom","year":"2021","unstructured":"Sandstrom A, Perroud N, Alda M, Uher R, Pavlova B. Prevalence of attention-deficit\/hyperactivity disorder in people with mood disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2021;143:380\u201391.","journal-title":"Acta Psychiatr Scand"},{"key":"3926_CR14","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/schbul\/sbae228","volume":"51","author":"N Cheng","year":"2025","unstructured":"Cheng N, Bryce S, Takagi M, Pert A, Rattray A, Fisher E, et al. The prevalence of attention deficit hyperactivity disorder in psychotic disorders: systematic review and meta-analysis. Schizophr Bull. 2025;51:1514\u201328.","journal-title":"Schizophr Bull"},{"key":"3926_CR15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1177\/10870547221085503","volume":"26","author":"D Adamis","year":"2022","unstructured":"Adamis D, Flynn C, Wrigley M, Gavin B, McNicholas F. ADHD in adults: a systematic review and meta-analysis of prevalence studies in outpatient psychiatric clinics. J Atten Disord. 2022;26:1523\u201334.","journal-title":"J Atten Disord"},{"key":"3926_CR16","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1007\/s00787-024-02436-4","volume":"33","author":"M Dolz","year":"2024","unstructured":"Dolz M, Tor J, Puig O, de la Serna E, Mu\u00f1oz-Samons D, Pardo M, et al. Clinical and neurodevelopmental predictors of psychotic disorders in children and adolescents at clinical high risk for psychosis: the CAPRIS study. Eur Child Adolesc Psychiatry. 2024;33:3925\u201335.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3926_CR17","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m13907","volume":"82","author":"I Baeza","year":"2021","unstructured":"Baeza I, de la Serna E, Amoretti S, Cuesta MJ, D\u00edaz-Caneja CM, Mezquida G, et al. Premorbid characteristics as predictors of early onset versus adult onset in patients with a first episode of psychosis. J Clin Psychiatry. 2021;82:21m13907.","journal-title":"J Clin Psychiatry"},{"key":"3926_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.chc.2019.08.017","volume":"29","author":"DI Driver","year":"2020","unstructured":"Driver DI, Thomas S, Gogtay N, Rapoport JL. Childhood-onset schizophrenia and early-onset schizophrenia spectrum disorders. An Update. Child Adolesc Psychiatr Clin. 2020;29:71\u201390.","journal-title":"An Update. Child Adolesc Psychiatr Clin."},{"key":"3926_CR19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/CHI.0b013e31818b1c63","volume":"48","author":"J Rapoport","year":"2009","unstructured":"Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry. 2009;48:10\u201318.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3926_CR20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S2215-0366(22)00402-3","volume":"10","author":"BK Burton","year":"2023","unstructured":"Burton BK, Krantz MF, Skovgaard LT, Brandt JM, Gregersen M, S\u00f8ndergaard A, et al. Impaired motor development in children with familial high risk of schizophrenia or bipolar disorder and the association with psychotic experiences: a 4-year Danish observational follow-up study. Lancet Psychiatry. 2023;10:108\u201318.","journal-title":"Lancet Psychiatry"},{"key":"3926_CR21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neubiorev.2021.11.027","volume":"132","author":"LE Pieters","year":"2022","unstructured":"Pieters LE, Nadesalingam N, Walther S, van Harten PN. A systematic review of the prognostic value of motor abnormalities on clinical outcome in psychosis. Neurosci Biobehav Rev. 2022;132:691\u2013705.","journal-title":"Neurosci Biobehav Rev"},{"key":"3926_CR22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ajmg.b.32812","volume":"183","author":"CB Solot","year":"2020","unstructured":"Solot CB, Moore TM, Crowley TB, Gerdes M, Moss E, McGinn DE, et al. Early language measures associated with later psychosis features in 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet. 2020;183:392\u2013400.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"3926_CR23","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1192\/j.eurpsy.2025.24","volume":"68","author":"BB Durdurak","year":"2025","unstructured":"Durdurak BB, Morales-Mu\u00f1oz I, Hosang GM, Marwaha S. ADHD symptom trajectories across childhood and early adolescence and risk for hypomanic symptoms in young adulthood. Eur Psychiatry. 2025;68:e37.","journal-title":"Eur Psychiatry"},{"key":"3926_CR24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1017\/S0033291719001089","volume":"50","author":"A Sandstrom","year":"2020","unstructured":"Sandstrom A, MacKenzie L, Pizzo A, Fine A, Rempel S, Howard C, et al. Observed psychopathology in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia. Psychol Med. 2020;50:1050\u20136.","journal-title":"Psychol Med"},{"key":"3926_CR25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1017\/S0954579419000385","volume":"32","author":"KJ Osborne","year":"2020","unstructured":"Osborne KJ, Vargas T, Mittal VA. Early childhood social communication deficits in youth at clinical high-risk for psychosis: associations with functioning and risk. Dev Psychopathol. 2020;32:559\u201372.","journal-title":"Dev Psychopathol"},{"key":"3926_CR26","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114793","volume":"316","author":"V Tikkanen","year":"2022","unstructured":"Tikkanen V, Siira V, Wahlberg K-E, Hakko H, Myllyaho T, L\u00e4ksy K, et al. Deficits in adolescent social functioning, dysfunctional family processes and genetic risk for schizophrenia spectrum disorders as risk factors for later psychiatric morbidity of adoptees. Psychiatry Res. 2022;316:114793.","journal-title":"Psychiatry Res"},{"key":"3926_CR27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jar.12654","volume":"33","author":"MG Mazza","year":"2020","unstructured":"Mazza MG, Rossetti A, Crespi G, Clerici M. Prevalence of co-occurring psychiatric disorders in adults and adolescents with intellectual disability: a systematic review and meta-analysis. J Appl Res Intellect Disabil. 2020;33:126\u201338.","journal-title":"J Appl Res Intellect Disabil"},{"key":"3926_CR28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.biopsych.2024.09.025","volume":"97","author":"A Lefrere","year":"2025","unstructured":"Lefrere A, Godin O, Jamain S, Dansou Y, Samalin L, Alda M, et al. Refining criteria for a neurodevelopmental subphenotype of bipolar disorders: a fondamental advanced centers of expertise for bipolar disorders study. Biol Psychiatry. 2025;97:806\u201315.","journal-title":"Biol Psychiatry"},{"key":"3926_CR29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neubiorev.2020.02.005","volume":"112","author":"S Kloiber","year":"2020","unstructured":"Kloiber S, Rosenblat JD, Husain MI, Ortiz A, Berk M, Quevedo J, et al. Neurodevelopmental pathways in bipolar disorder. Neurosci Biobehav Rev. 2020;112:213\u201326.","journal-title":"Neurosci Biobehav Rev"},{"key":"3926_CR30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neubiorev.2021.01.017","volume":"124","author":"C Schiweck","year":"2021","unstructured":"Schiweck C, Arteaga-Henriquez G, Aichholzer M, Edwin Thanarajah S, Vargas-C\u00e1ceres S, Matura S, et al. Comorbidity of ADHD and adult bipolar disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;124:100\u201323.","journal-title":"Neurosci Biobehav Rev"},{"key":"3926_CR31","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00787-025-02650-8","volume":"34","author":"MM Lilja","year":"2025","unstructured":"Lilja MM, Lichtenstein P, Serlachius E, Bhagia J, Malmberg K, Malm C, et al. Can response to ADHD medication be predicted? Eur Child Adolesc Psychiatry. 2025;34:2431\u201342.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3926_CR32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bdi.13414","volume":"26","author":"KW Miskowiak","year":"2024","unstructured":"Miskowiak KW, Obel ZK, Guglielmo R, Bonnin CDM, Bowie CR, Balanz\u00e1-Mart\u00ednez V, et al. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force. Bipolar Disord. 2024;26:216\u201339.","journal-title":"Bipolar Disord"},{"key":"3926_CR33","unstructured":"National Institute for Health and Care Excellence. Bipolar disorder: assessment and management. Clinical guideline [CG185]. 2014 (last updated 2 September 2025). https:\/\/www.nice.org.uk\/guidance\/cg185\/chapter\/Recommendations. Accessed 26 January 2026."},{"key":"3926_CR34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S2215-0366(25)00248-2","volume":"13","author":"S Cortese","year":"2026","unstructured":"Cortese S, Garcia-Argibay M, Oliver D, Chang Z, Farhat LC, Bloch MH, et al. Psychotic symptoms during pharmacological treatment of ADHD: clinical considerations and research needs. Lancet Psychiatry. 2026;13:266\u201374.","journal-title":"Lancet Psychiatry"},{"key":"3926_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2215-0366(24)00396-1","volume":"12","author":"M Garcia-Argibay","year":"2025","unstructured":"Garcia-Argibay M, Chang Z, Brikell I, Kuja-Halkola R, D\u2019Onofrio BM, Lichtenstein P, et al. Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals. Lancet Psychiatry. 2025;12:131\u20139.","journal-title":"Lancet Psychiatry"},{"key":"3926_CR36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2215-0366(19)30189-0","volume":"6","author":"C Hollis","year":"2019","unstructured":"Hollis C, Chen Q, Chang Z, Quinn PD, Viktorin A, Lichtenstein P, et al. Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study. Lancet Psychiatry. 2019;6:651\u20138.","journal-title":"Lancet Psychiatry"},{"key":"3926_CR37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamapsychiatry.2026.0152","volume":"83","author":"C Healy","year":"2026","unstructured":"Healy C, O\u2019Hare K, L\u00e5ng U, Mets\u00e4l\u00e4 J, Pulakka A, McGrath J, et al. Methylphenidate treatment and risk of psychotic disorder. JAMA Psychiatry. 2026;83:611\u20139. https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.0152.","journal-title":"JAMA Psychiatry"},{"key":"3926_CR38","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1001\/jamapsychiatry.2025.2311","volume":"82","author":"G Salazar de Pablo","year":"2025","unstructured":"Salazar de Pablo G, Aymerich C, Chart-Pascual JP, Solmi M, Torres-Cortes J, Abdelhafez N, et al. Occurrence of psychosis and bipolar disorder in individuals with attention-deficit\/hyperactivity disorder treated with stimulants: a systematic review and meta-analysis. JAMA Psychiatry. 2025;82:1103\u201312. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.2311.","journal-title":"JAMA Psychiatry"},{"key":"3926_CR39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1176\/appi.ajp.20230329","volume":"181","author":"LV Moran","year":"2024","unstructured":"Moran LV, Skinner JP, Shinn AK, Nielsen K, Rao V, Taylor ST, et al. Risk of incident psychosis and mania with prescription amphetamines. Am J Psychiatry. 2024;181:901\u20139.","journal-title":"Am J Psychiatry"},{"key":"3926_CR40","doi-asserted-by":"crossref","first-page":"e300876","DOI":"10.1136\/bmjment-2023-300876","volume":"27","author":"J Hamard","year":"2024","unstructured":"Hamard J, Rousseau V, Durrieu G, Garcia P, Yrondi A, Sommet A, et al. Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults. BMJ Ment Health. 2024;27:e300876.","journal-title":"BMJ Ment Health"},{"key":"3926_CR41","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa1813751","volume":"380","author":"LV Moran","year":"2019","unstructured":"Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S. Psychosis with methylphenidate or amphetamine in patients with ADHD. N Engl J Med. 2019;380:1128\u201338.","journal-title":"N Engl J Med"},{"key":"3926_CR42","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1017\/S0033291720000665","volume":"51","author":"L Riglin","year":"2021","unstructured":"Riglin L, Leppert B, Dardani C, Thapar AK, Rice F, O\u2019Donovan MC, et al. ADHD and depression: investigating a causal explanation. Psychol Med. 2021;51:1890\u20137.","journal-title":"Psychol Med"},{"key":"3926_CR43","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2019.12.003","volume":"88","author":"Z Chang","year":"2020","unstructured":"Chang Z, Quinn PD, O\u2019Reilly L, Sj\u00f6lander A, Hur K, Gibbons R, et al. Medication for attention-deficit\/hyperactivity disorder and risk for suicide attempts. Biol Psychiatry. 2020;88:452\u20138.","journal-title":"Biol Psychiatry"},{"key":"3926_CR44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaac.2023.05.025","volume":"63","author":"T Widding-Havneraas","year":"2024","unstructured":"Widding-Havneraas T, Zachrisson HD, Markussen S, Elwert F, Lyhmann I, Chaulagain A, et al. Effect of pharmacological treatment of attention-deficit\/hyperactivity disorder on criminality. J Am Acad Child Adolesc Psychiatry. 2024;63:433\u201342.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3926_CR45","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","volume":"385","author":"S Dalsgaard","year":"2015","unstructured":"Dalsgaard S, \u00d8stergaard SD, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet Lond Engl. 2015;385:2190\u20136.","journal-title":"Lancet Lond Engl"},{"key":"3926_CR46","doi-asserted-by":"crossref","first-page":"e083658","DOI":"10.1136\/bmj-2024-083658","volume":"390","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhu N, Sj\u00f6lander A, Nourredine M, Li L, Garcia-Argibay M, et al. ADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trials. BMJ. 2025;390:e083658.","journal-title":"BMJ"},{"key":"3926_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-05548-y","volume":"24","author":"Y Guo","year":"2024","unstructured":"Guo Y, Li J, Hu R, Luo H, Zhang Z, Tan J, et al. Associations between ADHD and risk of six psychiatric disorders: a Mendelian randomization study. BMC Psychiatry. 2024;24:99.","journal-title":"BMC Psychiatry"},{"key":"3926_CR48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2022-300642","volume":"26","author":"C Meisinger","year":"2023","unstructured":"Meisinger C, Freuer D. Understanding the causal relationships of attention-deficit\/hyperactivity disorder with mental disorders and suicide attempt: a network Mendelian randomisation study. BMJ Ment Health. 2023;26:e300642.","journal-title":"BMJ Ment Health"},{"key":"3926_CR49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2352-4642(23)00289-4","volume":"8","author":"R Abreg\u00fa-Crespo","year":"2024","unstructured":"Abreg\u00fa-Crespo R, Garriz-Luis A, Ayora M, Mart\u00edn-Mart\u00ednez N, Cavone V, Carrasco M\u00c1, et al. School bullying in children and adolescents with neurodevelopmental and psychiatric conditions: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2024;8:122\u201334.","journal-title":"Lancet Child Adolesc Health"},{"key":"3926_CR50","doi-asserted-by":"crossref","DOI":"10.1002\/jcv2.12169","volume":"3","author":"P Bali","year":"2023","unstructured":"Bali P, Sonuga-Barke E, Mohr-Jensen C, Demontis D, Minnis H. Is there evidence of a causal link between childhood maltreatment and attention deficit\/hyperactivity disorder? A systematic review of prospective longitudinal studies using the Bradford-Hill criteria. JCPP Adv. 2023;3:e12169.","journal-title":"JCPP Adv"},{"key":"3926_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1176\/appi.ajp.20220174","volume":"180","author":"JR Baldwin","year":"2023","unstructured":"Baldwin JR, Wang B, Karwatowska L, Schoeler T, Tsaligopoulou A, Munaf\u00f2 MR, et al. Childhood maltreatment and mental health problems: a systematic review and meta-analysis of quasi-experimental studies. Am J Psychiatry. 2023;180:117\u201326. https:\/\/doi.org\/10.1176\/appi.ajp.20220174.","journal-title":"Am J Psychiatry"},{"key":"3926_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00787-020-01574-9","volume":"31","author":"A Pastore","year":"2022","unstructured":"Pastore A, de Girolamo G, Tafuri S, Tomasicchio A, Margari F. Traumatic experiences in childhood and adolescence: a meta-analysis of prospective studies assessing risk for psychosis. Eur Child Adolesc Psychiatry. 2022;31:215\u201328.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3926_CR53","doi-asserted-by":"crossref","DOI":"10.1111\/eip.70123","volume":"20","author":"V Ricci","year":"2026","unstructured":"Ricci V, Barresi M, Di Salvo G, Maina G. Neurodevelopmental, pharmacological and substance use factors in the association between ADHD and first-episode non-affective psychosis: a systematic review. Early Interv Psychiatry. 2026;20:e70123.","journal-title":"Early Interv Psychiatry"},{"key":"3926_CR54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1192\/bjp.2025.104","volume":"226","author":"T Broughton","year":"2025","unstructured":"Broughton T, Lambert E, Wertz J, Agnew-Blais J. Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study. Br J Psychiatry. 2025;226:410\u20137.","journal-title":"Br J Psychiatry"},{"key":"3926_CR55","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/1467-9566.13443","volume":"44","author":"M Bergey","year":"2022","unstructured":"Bergey M, Chiri G, Freeman NLB, Mackie TI. Mapping mental health inequalities: the intersecting effects of gender, race, class, and ethnicity on ADHD diagnosis. Sociol Health Illn. 2022;44:604\u201323.","journal-title":"Sociol Health Illn"},{"key":"3926_CR56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/ajad.13133","volume":"30","author":"D Fluyau","year":"2021","unstructured":"Fluyau D, Revadigar N, Pierre CG. Systematic review and meta-analysis: treatment of substance use disorder in attention deficit hyperactivity disorder. Am J Addict. 2021;30:110\u201321.","journal-title":"Am J Addict"},{"key":"3926_CR57","doi-asserted-by":"crossref","DOI":"10.1016\/j.rasd.2021.101759","volume":"83","author":"Y Rong","year":"2021","unstructured":"Rong Y, Yang C-J, Jin Y, Wang Y. Prevalence of attention-deficit\/hyperactivity disorder in individuals with autism spectrum disorder: a meta-analysis. Res Autism Spectr Disord. 2021;83:101759.","journal-title":"Res Autism Spectr Disord"},{"key":"3926_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-022-00462-1","volume":"16","author":"L Franc\u00e9s","year":"2022","unstructured":"Franc\u00e9s L, Quintero J, Fern\u00e1ndez A, Ruiz A, Caules J, Fillon G, et al. Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteria. Child Adolesc Psychiatry Ment Health. 2022;16:27.","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"3926_CR59","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.biopsych.2025.03.004","volume":"98","author":"CA Dennison","year":"2025","unstructured":"Dennison CA, Martin J, Shakeshaft A, Riglin L, Powell V, Kirov G, et al. Early manifestations of neurodevelopmental copy number variants in children: a population-based investigation. Biol Psychiatry. 2025;98:924\u201333. https:\/\/doi.org\/10.1016\/j.biopsych.2025.03.004.","journal-title":"Biol Psychiatry"},{"key":"3926_CR60","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41588-022-01171-3","volume":"54","author":"M Mattheisen","year":"2022","unstructured":"Mattheisen M, Grove J, Als TD, Martin J, Voloudakis G, Meier S, et al. Identification of shared and differentiating genetic architecture for autism spectrum disorder, attention-deficit hyperactivity disorder and case subgroups. Nat Genet. 2022;54:1470\u20138.","journal-title":"Nat Genet"},{"key":"3926_CR61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.schres.2020.01.021","volume":"218","author":"E Bj\u00f6rkenstam","year":"2020","unstructured":"Bj\u00f6rkenstam E, Pierce M, Bj\u00f6rkenstam C, Dalman C, Kosidou K. Attention Deficit\/Hyperactivity Disorder and risk for non-affective psychotic disorder: the role of ADHD medication and comorbidity, and sibling comparison. Schizophr Res. 2020;218:124\u201330.","journal-title":"Schizophr Res"},{"key":"3926_CR62","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.biopsych.2016.02.018","volume":"80","author":"Z Chang","year":"2016","unstructured":"Chang Z, D\u2019Onofrio BM, Quinn PD, Lichtenstein P, Larsson H. Medication for attention-deficit\/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study. Biol Psychiatry. 2016;80:916\u201322.","journal-title":"Biol Psychiatry"},{"key":"3926_CR63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaac.2014.10.006","volume":"54","author":"L Fern\u00e1ndez de la Cruz","year":"2015","unstructured":"Fern\u00e1ndez de la Cruz L, Simonoff E, McGough JJ, Halperin JM, Arnold LE, Stringaris A. Treatment of children with Attention-Deficit\/Hyperactivity Disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA). J Am Acad Child Adolesc Psychiatry. 2015;54:62\u201370.e3.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3926_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-022-00515-5","volume":"16","author":"J Park","year":"2022","unstructured":"Park J, Lee DY, Kim C, Lee YH, Yang S-J, Lee S, et al. Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea. Child Adolesc Psychiatry Ment Health. 2022;16:80.","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"3926_CR65","doi-asserted-by":"crossref","first-page":"e2345793","DOI":"10.1001\/jamanetworkopen.2023.45793","volume":"6","author":"SM Jeon","year":"2023","unstructured":"Jeon SM, Lee DY, Cha S, Kwon J-W. Psychiatric comorbidities and schizophrenia in youths with attention-deficit\/hyperactivity disorder. JAMA Netw Open. 2023;6:e2345793.","journal-title":"JAMA Netw Open"},{"key":"3926_CR66","volume":"42","author":"JB Schulze","year":"2025","unstructured":"Schulze JB, Simnacher F, M\u00fcller TJ, Kirchebner J, Quatela F, Mikutta C, et al. ADHD and schizophrenia: mere prodromal variant or homogeneous subgroup? Schizophr Res Cogn. 2025;42:100374.","journal-title":"Schizophr Res Cogn"},{"key":"3926_CR67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/00048674221106669","volume":"57","author":"F Bartoli","year":"2023","unstructured":"Bartoli F, Callovini T, Cavaleri D, Cioni RM, Bachi B, Calabrese A, et al. Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: a meta-analysis. Aust N Z J Psychiatry. 2023;57:34\u201348.","journal-title":"Aust N Z J Psychiatry"},{"key":"3926_CR68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wps.20440","volume":"16","author":"MJ Owen","year":"2017","unstructured":"Owen MJ, O\u2019Donovan MC. Schizophrenia and the neurodevelopmental continuum:evidence from genomics. World Psychiatry. 2017;16:227\u201335.","journal-title":"World Psychiatry"},{"key":"3926_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-019-0599-y","volume":"9","author":"OO Gudmundsson","year":"2019","unstructured":"Gudmundsson OO, Walters GB, Ingason A, Johansson S, Zayats T, Athanasiu L, et al. Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder. Transl Psychiatry. 2019;9:1\u20139.","journal-title":"Transl Psychiatry"},{"key":"3926_CR70","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S2215-0366(20)30312-6","volume":"7","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim JY, Lee J, Jeong GH, Lee E, Lee S, et al. Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review. Lancet Psychiatry. 2020;7:955\u201370.","journal-title":"Lancet Psychiatry"},{"key":"3926_CR71","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2215-0366(20)30057-2","volume":"7","author":"C Davies","year":"2020","unstructured":"Davies C, Segre G, Estrad\u00e9 A, Radua J, Micheli AD, Provenzani U, et al. Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis. Lancet Psychiatry. 2020;7:399\u2013410.","journal-title":"Lancet Psychiatry"},{"key":"3926_CR72","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","volume":"171","author":"M Schneider","year":"2014","unstructured":"Schneider M, Debban\u00e9 M, Bassett AS, Chow EWC, Fung WLA, van den Bree M, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 deletion syndrome. Am J Psychiatry. 2014;171:627\u201339.","journal-title":"Am J Psychiatry"},{"key":"3926_CR73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.bp.113.132324","volume":"204","author":"M Niarchou","year":"2014","unstructured":"Niarchou M, Zammit S, van Goozen SHM, Thapar A, Tierling HM, Owen MJ, et al. Psychopathology and cognition in children with 22q11.2 deletion syndrome. Br J Psychiatry J Ment Sci. 2014;204:46\u201354.","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"3926_CR74","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.schres.2018.07.044","volume":"204","author":"M Niarchou","year":"2019","unstructured":"Niarchou M, Chawner SJRA, Fiksinski A, Vorstman JAS, Maeder J, Schneider M, et al. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome. Schizophr Res. 2019;204:320\u20135.","journal-title":"Schizophr Res"},{"key":"3926_CR75","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41576-025-00843-0","volume":"26","author":"MJ Owen","year":"2025","unstructured":"Owen MJ, Bray NJ, Walters JTR, O\u2019Donovan MC. Genomics of schizophrenia, bipolar disorder and major depressive disorder. Nat Rev Genet. 2025;26:862\u201377.","journal-title":"Nat Rev Genet"},{"key":"3926_CR76","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1038\/s41380-019-0613-z","volume":"26","author":"KS O\u2019Connell","year":"2021","unstructured":"O\u2019Connell KS, Shadrin A, Bahrami S, Smeland OB, Bettella F, Frei O, et al. Identification of genetic overlap and novel risk loci for attention-deficit\/hyperactivity disorder and bipolar disorder. Mol Psychiatry. 2021;26:4055\u201365.","journal-title":"Mol Psychiatry"},{"key":"3926_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0817-7","volume":"10","author":"WR Reay","year":"2020","unstructured":"Reay WR, Cairns MJ. Pairwise common variant meta-analyses of schizophrenia with other psychiatric disorders reveals shared and distinct gene and gene-set associations. Transl Psychiatry. 2020;10:134.","journal-title":"Transl Psychiatry"},{"key":"3926_CR78","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00787-024-02479-7","volume":"34","author":"H Peyre","year":"2025","unstructured":"Peyre H, Iftimovici A, Ellul P, Krebs M-O, Delorme R, Baghdadli A, et al. Investigating the increased risk of schizophrenia and bipolar disorders in relatives of ADHD probands using colocalization analysis of common genetic variants. Eur Child Adolesc Psychiatry. 2025;34:351\u20135.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3926_CR79","doi-asserted-by":"crossref","first-page":"28","DOI":"10.61373\/gp024i.0040","volume":"1","author":"MJ Owen","year":"2024","unstructured":"Owen MJ, O\u2019Donovan MC. The genetics of cognition in schizophrenia. Genomic Psychiatry. 2024;1:28\u201335.","journal-title":"Genomic Psychiatry"},{"key":"3926_CR80","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/mp.2017.78","volume":"23","author":"KS Kendler","year":"2018","unstructured":"Kendler KS, Ohlsson H, Keefe RSE, Sundquist K, Sundquist J. The joint impact of cognitive performance in adolescence and familial cognitive aptitude on risk for major psychiatric disorders: a delineation of four potential pathways to illness. Mol Psychiatry. 2018;23:1076\u201383.","journal-title":"Mol Psychiatry"},{"key":"3926_CR81","unstructured":"Royal College of Psychiatrists. The role of genetic testing in mental health settings. College Report CR237. London: Royal College of Psychiatrists; 2023. https:\/\/www.rcpsych.ac.uk\/improving-care\/campaigning-for-better-mental-health-policy\/college-reports\/2023-college-reports\/the-role-of-genetic-testing-in-mental-health-settings-(cr237). Accessed 5 October 2026."},{"key":"3926_CR82","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00787-019-01428-z","volume":"29","author":"C O\u2019Connor","year":"2020","unstructured":"O\u2019Connor C, Downs J, Shetty H, McNicholas F. Diagnostic trajectories in child and adolescent mental health services: exploring the prevalence and patterns of diagnostic adjustments in an electronic mental health case register. Eur Child Adolesc Psychiatry. 2020;29:1111\u201323.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3926_CR83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1192\/bjp.bp.110.078741","volume":"198","author":"A Hassan","year":"2011","unstructured":"Hassan A, Agha SS, Langley K, Thapar A. Prevalence of bipolar disorder in children and adolescents withattention-deficit hyperactivity disorder. Br J Psychiatry. 2011;198:195\u20138.","journal-title":"Br J Psychiatry"},{"key":"3926_CR84","unstructured":"NHS England ADHD Taskforce. Report of the independent ADHD Taskforce: Part 2. London: NHS England; 2025. https:\/\/www.england.nhs.uk\/publication\/report-of-the-independent-adhd-taskforce\/. Accessed 5 October 2026."},{"key":"3926_CR85","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/00048674231166329","volume":"57","author":"T May","year":"2023","unstructured":"May T, Birch E, Chaves K, Cranswick N, Culnane E, Delaney J, et al. The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 2023;57:1101\u201316.","journal-title":"Aust N Z J Psychiatry"},{"key":"3926_CR86","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biopsych.2018.12.009","volume":"86","author":"AW Charney","year":"2019","unstructured":"Charney AW, Stahl EA, Green EK, Chen C-Y, Moran JL, Chambert K, et al. Contribution of rare copy number variants to bipolar disorder risk is limited to schizoaffective cases. Biol Psychiatry. 2019;86:110\u20139.","journal-title":"Biol Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03926-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:36:24Z","timestamp":1792042584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03926-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":86,"alternative-id":["3926"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03926-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MJO reports receiving grant funding from Akrivia Health for work outside the scope of this manuscript. AT has served as Chair of the NHS-England ADHD Taskforce and Co-chair on the Welsh Government Neurodivergence Ministerial Advisory Group (unpaid) and receives royalties from Wiley for editing Rutter\u2019s Textbook of Child and Adolescent Psychiatry. All other authors report no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Ethical approval was not required as this Perspective article did not involve human participants or animal subjects.","order":2,"name":"Ethics","label":"Ethics Declaration","group":{"name":"EthicsHeading","label":"Ethics"}}]}}